Association of Concurrent Amiodarone and Beta-Blocker Therapy at Discharge With 30-Day Rehospitalization After Atrial Fibrillation Hospitalization
Teddy A Teddy, Spencer Cadet, Edidiong Okon-Ben, Fraol T Erega, Abdelwahab Ahmed, Siri Vummaneni, Mustafa Marzoug, Kendall Bell · 2026
Read Association of Concurrent Amiodarone and Beta-Blocker Therapy at Discharge With 30-Day Rehospitalization After Atrial Fibrillation Hospitalization by Teddy A Teddy, Spencer Cadet, Edidiong Okon-Ben, Fraol T Erega, Abdelwahab Ahmed, Siri Vummaneni, Mustafa Marzoug, Kendall Bell (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13274198.txt.
Description
Teddy Teddy and co-authors ask whether sending atrial fibrillation patients home on two rhythm drugs together keeps them out of hospital. Their 2026 study uses a large health records platform and matches 1,323 patients on the amiodarone plus beta-blocker pair against 1,323 similar patients on other therapy.
Within 30 days, 13.6 percent of the paired-drug group were readmitted for any cause, against 16.9 percent of the others. Readmissions for the rhythm problem itself and urgent rhythm visits also ran lower. Death rates did not differ. The trade-off showed in safety: slow pulse and low blood pressure visits were more common on the pair. The authors frame the combo as a net win that still demands respect for its side effects.
Catalog record
| CREATOR | Teddy A Teddy, Spencer Cadet, Edidiong Okon-Ben, Fraol T Erega, Abdelwahab Ahmed, Siri Vummaneni, Mustafa Marzoug, Kendall Bell |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |